用 pembrolizumab 治疗阴道清晰细胞癌的完全持久反应:一个病例报告
Hector S Porragas-Paseiro1, Saketh Guntupalli1, Jessie Xiong2
1University of Colorado School of Medicine, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, United States.
Gynecologic oncology reports
|August 28, 2023
概括
这项研究呈现了一种通过Pembrolizumab成功治疗的复发性阴道清细胞癌的病例. 这种免疫疗法为这种罕见的癌症提供了潜在的新治疗选择.
科学领域:
- 妇科瘤学 妇科瘤学
- 医学瘤学 医学瘤学
- 免疫治疗是一种免疫疗法.
背景情况:
- 阴道的初级透明细胞腺癌是一种罕见的恶性瘤,与子宫内乙醇 (DES) 暴露有关.
- 标准治疗包括手术,放射和化疗.
- 免疫疗法在瘤学中越来越多地被探索,KEYNOTE 826在宫腺癌中显示出好处.
更多相关视频
15:24Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
3.2K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:27Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555